HIV

Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Stat
Tue, 05/14/19 - 11:39 pm
Gilead Sciences
AIDS
HIV
generics
competition
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
BioSpace
Mon, 05/13/19 - 08:10 pm
Gilead Sciences
HIV
Truvada
competition
Teva Pharmaceutical
Gilead patent cliff looms as Teva plans generic Truvada launch
Pharmaforum
Mon, 05/13/19 - 09:22 am
Gilead Sciences
HIV
Truvada
generics
Teva Pharmaceuticals
Gilead will donate meds for US push to end HIV epidemic
Yahoo/AP
Thu, 05/9/19 - 11:39 pm
Gilead Sciences
HIV
donations
Truvada
ViiV Submits NDA for Once-Per-Month HIV Injectable
BioSpace
Mon, 04/29/19 - 08:54 pm
ViiV Healthcare
FDA
HIV
HIV-1
cabotegravir
rilpivirine
Department of Justice Reviewing Gilead and CDC’s HIV Patents
BioSpace
Thu, 04/25/19 - 10:34 am
DOJ
patents
Gilead Sciences
CDC
HIV
Truvada
Going viral? J&J tries to spark a Twitterstorm for the latest data on its HIV med
Endpoints
Fri, 04/12/19 - 10:06 am
JNJ
HIV
Symtuza
social media
twitter
GSK wins U.S. nod for two-drug HIV combination
Yahoo/Reuters
Tue, 04/9/19 - 08:25 am
GSK
FDA
HIV
Dovato
Gilead sees Descovy as successor to Truvada for HIV PrEP
BioCentury
Fri, 04/5/19 - 11:39 pm
Gilead Sciences
Descovy
Truvada
HIV
PrEP
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Motley Fool
Sun, 03/24/19 - 12:08 pm
Gilead Sciences
GS-6207
HIV
Gilead raises prices on top-selling HIV treatments
Biopharma Dive
Tue, 03/19/19 - 10:34 am
Gilead Sciences
drug pricing
HIV
Gilead shares early clinical data on HIV capsid inhibitor
Fierce Biotech
Fri, 03/8/19 - 11:35 am
Gilead Sciences
HIV
GS-6207
clinical trials
Monthly shots control HIV as well as daily pills in two big studies
Stat
Thu, 03/7/19 - 09:21 pm
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
BioPharma Dive
Wed, 03/6/19 - 08:13 pm
Gilead Sciences
HIV
Descovy
Truvada
clinical trials
Trump's HIV pledge comes as Gilead pumps cash into Truvada for PrEP
Fierce Pharma
Wed, 02/6/19 - 01:30 pm
Gilead Sciences
HIV
Descovy
PrEP
Donald Trump
How to stop a lack of diversity undermining clinical trial data
Financial Times
Sat, 01/19/19 - 06:31 pm
clinical trials
race
ethnicity
HIV
hypertension
cancer
7 Things to Expect for Gilead Sciences in 2019
Motley Fool
Tue, 01/8/19 - 09:12 am
Gilead Sciences
JPMHC 2019
HIV
hepatitis C
M&A
Daniel O'Day
Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment
Biopharma Dive
Wed, 12/12/18 - 12:07 am
GSK
ViiV Healthcare
HIV
ViiV Healthcare’s HIV-1 drug fostemsavir succeeds in phase 3 trial
Pharmaceutical Business Review
Thu, 11/1/18 - 10:47 am
ViiV Healthcare
HIV
clinical trials
fostemsavir

Pages